Certara, Inc. (NASDAQ:CERT) Stock Holdings Lessened by California State Teachers Retirement System

Posted by Defense World Staff on Aug 25th, 2023

California State Teachers Retirement System reduced its holdings in Certara, Inc. (NASDAQ:CERT – Free Report) by 1.7% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 134,682 shares of the company’s stock after selling 2,364 shares during the quarter. California State Teachers Retirement System owned approximately 0.08% of Certara worth $3,247,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of CERT. William Blair Investment Management LLC lifted its position in Certara by 32.1% in the 4th quarter. William Blair Investment Management LLC now owns 6,732,603 shares of the company’s stock valued at $108,193,000 after purchasing an additional 1,634,607 shares during the last quarter. ArrowMark Colorado Holdings LLC lifted its position in Certara by 27.6% in the 4th quarter. ArrowMark Colorado Holdings LLC now owns 6,129,926 shares of the company’s stock valued at $98,508,000 after purchasing an additional 1,326,060 shares during the last quarter. Clearbridge Investments LLC lifted its position in Certara by 58.7% in the 1st quarter. Clearbridge Investments LLC now owns 3,200,895 shares of the company’s stock valued at $68,755,000 after purchasing an additional 1,183,859 shares during the last quarter. Norges Bank bought a new stake in Certara in the 4th quarter valued at about $15,915,000. Finally, Edmond DE Rothschild Holding S.A. lifted its position in Certara by 1,071.7% in the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 765,446 shares of the company’s stock valued at $12,301,000 after purchasing an additional 700,117 shares during the last quarter. 67.34% of the stock is currently owned by institutional investors.

Insider Transactions at Certara

In other news, insider Patrick F. Smith sold 19,104 shares of Certara stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $21.55, for a total value of $411,691.20. Following the transaction, the insider now directly owns 59,975 shares of the company’s stock, valued at $1,292,461.25. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

CERT has been the topic of several recent research reports. Barclays cut their price objective on shares of Certara from $18.00 to $16.00 and set an “equal weight” rating on the stock in a research report on Friday, August 11th. Credit Suisse Group dropped their price target on shares of Certara from $27.00 to $21.00 and set an “outperform” rating on the stock in a research report on Thursday, August 10th. TheStreet downgraded shares of Certara from a “c-” rating to a “d+” rating in a research report on Friday, June 16th. Bank of America dropped their price target on shares of Certara from $27.00 to $24.00 and set a “buy” rating on the stock in a research report on Tuesday, August 15th. Finally, William Blair downgraded shares of Certara from an “outperform” rating to a “market perform” rating in a research report on Thursday, August 10th. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $21.13.

Check Out Our Latest Stock Analysis on CERT

Certara Stock Performance

Shares of CERT opened at $15.89 on Friday. The firm’s 50 day moving average is $17.98 and its 200-day moving average is $20.19. The stock has a market capitalization of $2.54 billion, a P/E ratio of 132.43, a P/E/G ratio of 1.06 and a beta of 1.42. The company has a debt-to-equity ratio of 0.26, a current ratio of 3.43 and a quick ratio of 3.43. Certara, Inc. has a 12-month low of $10.60 and a 12-month high of $24.96.

Certara (NASDAQ:CERT – Get Free Report) last released its earnings results on Wednesday, August 9th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. The business had revenue of $90.45 million for the quarter, compared to the consensus estimate of $92.04 million. Certara had a net margin of 5.45% and a return on equity of 5.56%. Equities research analysts anticipate that Certara, Inc. will post 0.34 EPS for the current fiscal year.

Certara Company Profile

(Free Report)

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development.